The Mitogen-Activated Protein Kinase cascade operates downstream of Ras to convey cell surface signals to the nucleus via nuclear translocation of ERK1 and ERK2. We and others have recently demonstrated that activation of ERK1/2 by growth factors is required for proliferation of intestinal epithelial crypt cells. However, it remained to be established whether ERK1/2 activation alone was sufficient to trigger intestinal epithelial cell proliferation. To this aim, retrovirus encoding the HA-tagged MEK1 wild type (wtMEK), the upstream activator of ERK1/2, or a constitutive active mutant of MEK1 (MEK1-S218D/S222D, caMEK) were used to infect non immortalized human normal intestinal epithelial crypt cell cultures (HIEC) and rodent 2
INTRODUCTION
The human intestinal epithelium is in a constant state of self-renewal, with complete mucosal turnover occurring every 3-5 days. Intestinal epithelial cells are generated from a fixed stem-cell population functionally localized in the lower portion of the intestinal crypts, giving rise to four primary epithelial cell types : absorptive enterocytes, goblet cells, Paneth cells and enteroendocrine cells (5) . The differentiation of each cell type takes place as cells move either upwards into the villus (absorptive, mucus and endocrine cells) or concentrate downwards at the bottom of the crypt (Paneth cells) (5) . The mechanisms that direct these complex events and migration are most likely multiple and are currently poorly understood. Elucidation of these mechanisms would be invaluable not only in delineating normal cell processes leading to the differentiated phenotype but also in providing insight regarding abnormal processes, such as neoplasia formation, that can occur when these mechanisms go awry.
Mammalian cells express multiple mitogen-activated protein (MAP) kinases that mediate the effects of extracellular signals on a wide array of biological processes. Three distinct MAPK cascades have been described, all linked to separate signal transduction pathways resulting in the final activation of either Extracellular Signal Regulated Kinases (ERK) 1/2, p38 / / / , or Jun kinases (JNKs) 1/2/3 (24) . Depending on cellular context, extracellular signals are thought to elicit a specific cellular response (proliferation/differentiation/apoptosis) through the preferential activation of one of the MAPK cascades, all of which have distinct spectra of substrates (13) .
In the majority of cell types, including intestinal epithelial crypt cells (2, 14, 30, 34, 53) , mitogenic signals are relayed from the cytoplasm into the nucleus by nuclear translocation of the ubiquitously expressed ERK1 and ERK2, resulting in activation of a range of transcription factors such as Elk-1, c-Ets-1, and c-Ets-2 (60) . The upstream activators of ERK1/2 (MEK1/2, Raf and Ras), on the other hand, remain cytoplasmic and/or membrane-bound (49, 61) .
Upon strong and persistent agonist stimulation, the ERK-mediated signals are attenuated and even terminated through various mechanisms, including the early induction of specific MAPK phosphatases (MKPs) (10, 49, 61) .
In proliferation-prone cells, all components of the signal transduction cascade (Ras, Raf, MEK, ERK) are sequentially activated in response to serum growth factors. Ras has been shown to be crucial for cell proliferation since expression of permanently active forms of this protein triggers the cascade and leads to fibroblast (20, 33, 63, 69) and epithelial cell transformation (52, 66) . This indicates that Ras activity is sufficient to bypass growth factor requirements. Although mutant Ras is most frequently associated with human epithelial cellderived tumors (8) , the majority of Ras signal transduction and transformation studies have been performed in rodent immortalized fibroblasts (6) . In immortal rodent lines, transformation by oncogenic Ras involves its ability to bind and activate a series of effector proteins, including Raf-1, phosphatidyl inositol 3-kinase (PI-3K) and Ral.GDS (64, 65) . Each of these proteins, in turn, activates distinct downstream targets, thereby producing different aspects of the transformed phenotypes. Although each of these effector pathways contribute to the transforming activity of Ras in immortal rodent fibroblasts, activation of the MAPK cascade is clearly sufficient (9, 12, 15, 39, 57) . However, it has been previously reported that activated Raf-1, despite triggering constitutively elevated ERK1/2 activities, fails to cause morphologic and growth transformation 4 of immortal rat intestinal cells (RIE-1) (43) . This observation could suggest that the relative contribution of ERK pathway to cell transformation may be determined by genetic background.
However, blockade of the MEK/ERK cascade suppresses growth of colon tumors in vivo, suggesting that the ERK activation is indeed involved in intestinal tumor progression (55) .
Virtually all studies examining MEK/ERK signaling in intestinal systems have utilized rodent immortal or human tumor-derived cell lines harboring unknown genetic alterations. Hence, the current study analyzed whether MEK/ERK activation alone is sufficient to trigger human cell proliferation and transformation, taking advantage of the recent generation of non immortalized human normal intestinal epithelial crypt cell cultures. The HIEC human diploid cell line, derived by Perreault and Beaulieu (46) from normal fetal (14 to 18 weeks of gestation)
intestinal tissue, has a finite lifetime and thus provides a new avenue for investigating, in human cells, the potential implication of MEK/ERK signaling pathway in intestinal epithelial cell proliferation and transformation. The role of this pathway was also further investigated in IEC-6 cells, an established rat intestinal cell line that is immortalized but reported to display properties of normal epithelial cells (50, 53) . IgG for 1 h. Blots were visualized using the Amersham ECL system. Protein concentrations were measured using a modified Lowry procedure with bovine serum albumin as standard (47) . Soft-agar Growth assay : Anchorage-independent growth was evaluated as described by Diaz et al. (18) . Briefly, cells were plated at 2 x 10 5 cells/well in complete DMEM containing 0.6% agar in 6-well plates. Medium was added (500 l/well) twice a week to maintain constant humidity. RT-PCR analysis : RNA was purified from cultured cells using the Trizol reagent (Invitrogen). We next compared the kinase activities of both wtMEK and caMEK. Exogenous MEK activities were measured following immunoprecipitation with antibodies against HA tag and using recombinant ERK2 protein as substrate. Fig. 1B shows that caMEK-expressing HIEC and IEC-6 cells exhibited approximately 30-fold more MEK activity when compared to wtMEKexpressing HIEC and IEC-6 cells after normalization of expression levels.
MATERIAL AND METHODS

Materials
Expression Vectors and Reporter Constructs
Effect of wtMEK and caMEK expression on HIEC and IEC-6 cell proliferation.
HIEC and IEC-6 cells are highly dependent upon growth factor addition for reinitiation of DNA synthesis and cell proliferation. Therefore, expression of any active gene product that lies along the growth factor signaling pathway is expected to relax the growth factor requirement for DNA synthesis and cell proliferation. The proliferative properties of these cell populations were first monitored by growth curves. HIEC and IEC-6 cells transduced for wtMEK or caMEK or empty vector (pLXIN) were plated at low density and cell numbers counted. As expected, control (pLXIN)-and wtMEK-expressing HIEC ( Fig. 2A ) cell populations grew steadily and reached confluence by day 5 post-seeding. By contrast, caMEK-expressing HIEC cells did not proliferate and stopped accumulating well before reaching confluence ( Fig. 2A) . In addition, the state of pRb hyperphosphorylation was also analyzed which, in the late G1 phase, is a landmark for cells passing the restriction point and entering S phase (41) . In serum-deprived wtMEK-expressing HIEC, pRb was exclusively found in its hypophosphorylated state (Fig. 2B ), while pRb inactivation (hyperphosphorylated form) became apparent 20 h after serum stimulation. In contrast, pRb hyperphosphorylation was never detected in caMEK-expressing HIEC cells indicating that these cells remained arrested in G0/G1 phase and thus did not progress into the cell cycle (Fig. 2B ). To further evaluate the impact of strong activation of MEK/ERK signaling on HIEC cell proliferation, previously characterized expression constructs for wtMEK and caMEK were transiently transfected with a plasmid construction containing the E2F-responsive element of the thymidine kinase promoter linked to a luciferase reporter gene (see Methods) which represents a sensitive reporter of growth-factor induced cell cycle progression and S-phase entry (16) . Ectopic expression of caMEK significantly inhibited thymidine kinase gene expression by 50% (Fig. 2C) . In marked contrast, wtMEK expression had no significant effect on thymidine kinase expression when compared to controls (empty vector). Taken together these results indicate that strong and persistent activation of MEK/ERK signaling in non immortalized human intestinal crypt cells induces cell cycle arrest.
In IEC-6, there were no significant changes detected in the growth rate of caMEKexpressing cells when compared to pLXIN-and wtMEK-expressing cells during the initial exponential growth in medium containing 5% serum. However, a significant change in saturation density was clearly apparent in caMEK-expressing cells which continued to proliferate after reaching confluency, in contrast to pLXIN-and wtMEK-expressing cells which became contactinhibited at day 5 post-seeding (Fig. 2D) . Moreover, there was no Rb phosphorylation detected in post-confluent pLXIN-and wtMEK-expressing cells indicating that these cells were contactinhibited and arrested in G1 phase. By contrast, in the cell populations expressing caMEK, a significant proportion of cells were permanently cycling after confluency as judged by the detection of hyperphosphorylated pRb (Fig. 2E) .
Constitutive active mutants of MEK1 have been reported to induce growth factor relaxation when expressed in immortalized fibroblasts (12) . Therefore, dose-responses of FBSinduced reinitiation of DNA synthesis were consequently measured in populations of IEC-6 cells expressing pLXIN, wtMEK and caMEK. The serum dose-responses from G0-arrested pLXINand wtMEK-expressing cells were identical (data not shown). In marked contrast to wtMEK, expression of caMEK induced a growth factor-relaxation for DNA synthesis. Indeed, in cell populations expressing caMEK, a significant proportion of cells were permanently cycling in either total absence or in low concentrations of serum (0.1%) as judged by the high rates of thymidine incorporation (Fig. 2F ). These results demonstrate that expression of a permanently active MEK is sufficient to disrupt growth control and allow autonomous cell cycling in immortalized intestinal epithelial crypt cells.
Effect of wtMEK and caMEK expression on HIEC and IEC-6 cell morphology.
Morphological examination of HIEC cells arrested by caMEK revealed that cells remained attached to the plates for at least one month (data no shown) and acquired a large and flat morphology (Fig. 3) . These caMEK-expressing cells remained arrested in a metabolically active state for at least the duration of the observation period (>1month). No evidences of apoptosis (i.e. no observed cell detachment or nuclear fragmentation) was detected in caMEK-14 expressing HIEC cells, 30 days after infection (data not shown). Moreover, these HIEC cells accumulated SA--gal (Fig. 3, see arrows) , a biomarker for senescent cells (19) , demonstrating that constitutive activation of the MEK/ERK cascade in human intestinal crypt cells produces premature senescence.
Since caMEK-expressing IEC-6 cells were growth factor-relaxed, sensitivity of IEC-6 cells to transformation was determined by constitutively activated mutant of MEK. Few or no morphological changes were readily detectable in exponentially growing caMEK-expressing IEC-6 cells (data not shown). However, at higher cell densities, the caMEK-expressing cells formed foci in contrast to pLXIN-and wtMEK-expressing epithelioid cells (Fig. 4A, panels 1-3 ).
The multi-layered morphology in caMEK-expressing cells became apparent at cell densities in which pLXIN-and wtMEK-expressing cells were forming a monolayer of contact-inhibited cells (Fig. 4B, panels 1 and 2) . Furthermore, caMEK-expressing cells, but not wtMEK-expressing cells, showed the ability to form colonies in soft agar (Fig. 4C) . These results indicate that constitutive activation of MEK1 in IEC-6 cells leads to morphological transformation.
Effect of wtMEK and caMEK on endogenous ERK signaling.
The consequences of stable expression of the active form of caMEK on activation of endogenous ERK were analyzed in resting and stimulated HIEC and IEC-6 cells. As shown in 5B ). In IEC-6 cell populations, expression and activity of ERK1/2 remained unaffected in asynchronously growing and confluent pLXIN-, wtMEK-and caMEK-expressing cells (Fig. 5D ).
However, an additional species with low electrophoretic mobility was detected with the antibody recognizing the bi-phosphorylated and activated forms of ERK1/2 in all three IEC-6 cell populations (Fig. 5D, see arrowhead) . Of note, this higher molecular mass form was prominent in confluent caMEK-expressing cells and appeared to correlate nicely with IEC-6 cell proliferation.
Indeed, this band dramatically decreased as soon as pLXIN-and wtMEK-expressing cells reached confluence to almost undetectable levels in post-confluent G1 arrested cells.
In a recent study, Yung et al. (68) cloned a 46-kDa ERK isoform, termed ERK1b, which is an alternatively spliced form of ERK1, containing a 26-amino acid insertion between residues 340 and 341 of ERK1. Unlike the uniform pattern of expression of ERK1 and ERK2, ERK1b was confined to several tissues including heart, brain, lung and kidney. However, the expression of ERK1b in the intestinal epithelium still remained to be demonstrated. RT-PCR analysis was henceforth performed to evaluate ERK1 transcripts from rat intestinal mucosae and from wtMEK-and caMEK-expressing IEC-6 cell lines. Fig. 5E illustrates the size of PCR products obtained with primers derived from the sequence of ERK1. Two amplified products were obtained: the expected 274 bp band (ERK1) and a second 352 bp band in intestinal mucosae as well as in IEC-6 cell populations, indicating that ERK1b was indeed expressed in intestinal epithelial cells. This suggests that the slower migrating form detected with the phospho-ERK antibodies (Fig. 5D , see arrowhead) may represent ERK1b. RT-PCR analysis demonstrates that neither wtMEK nor caMEK expression affected the expression of ERK1b (Fig. 5E ). Taken together, our results demonstrate that, in contrast to ERK1 and ERK2, ERK1b phosphorylation levels are significantly enhanced in caMEK-expressing IEC-6 cells, suggesting that ERK1b could contribute to the deregulation of contact inhibition cell growth and transformation of these cells.
Effect of wtMEK and caMEK on senescence-associated proteins and G1-phase regulatory proteins.
Cellular senescence and transformation are normally accompanied by a series of changes that together distinguish senescence from quiescence or transformation. These changes involve altered expression of cell cycle proteins including up-regulation of p53, p21 and p16 for senescence (1, 4, 37, 42, 51, 56) and for intestinal cancer, up-regulation of cyclins and/or cyclindependent kinases (3, 45, 54, 58) and down-regulation of p27 Kip1 (38, 59) . Interestingly, caMEK induced p53 (about 4-fold induction), p21 (about 3.3-fold induction) and p16 (about 3.7-fold induction) expression in HIEC cells (Fig. 6A) . It should be noted that these effects require constitutive active MEK activation, since HIEC cells overexpressing a wild-type MEK allele grow normally and display normal low levels of p53, p21 and p16. These results confirm that the cell-cycle arrest produced by activated MEK is characteristic of cellular senescence. In contrast to HIEC, there were no significant differences in expression levels of p21 in IEC-6 cells expressing wtMEK or caMEK; however, after densitometric analyses, we found a modest decrease (around 30%) in p53 protein levels in caMEK-expressing cells (Fig. 6A) . Finally, Western blot analysis using two different antibodies failed to detect p16 protein in wtMEK-and caMEK-expressing IEC-6 cells as well as in parental IEC-6 cell line (data not shown).
While stable expression of caMEK provoked cell cycle arrest and senescence in HIEC cells, it otherwise promoted IEC-6 cell proliferation and transformation. Indeed, in IEC-6 cell populations expressing caMEK, a significant proportion of cells were permanently cycling after confluency (see Fig. 2D and 2E). In a first attempt to identify the "cooperating" factors that ARF expression in turn stabilizes p53 and leads to cell-cycle arrest or apoptosis unless there is occurrence of a second lesion such as a mutation in ARF itself or p53 (7, 44) . Methylation of the p16 and/or Arf promoters in the Ink4a/Arf locus has been found in about one-half of colon carcinomas and adenomas (26) , suggesting that the locus may suppress early stages of development of this tumor type. Furthermore, it has been reported that ARF is epigenetically inactivated in several colorectal cell lines and its expression is restored by treatment with demethylating agents (22) . Therefore, one could speculate that the failure to induce p19 ARF expression in caMEK-expressing IEC-6 cells may explain the failure to induce p53. Restriction digesting-based methylation analysis and methylation-specific PCR are required to determine the methylation status of the p16 and ARF promoters in IEC-6 cells. Therefore, our results confirm the view that premature senescence may act as a fail-safe mechanism to limit the transforming potential of excessive Ras/MAPK signaling not only in fibroblasts but also in epithelial cells, the same cell type from which the majority of Ras mutation positive cancers arise (8) .
In a first attempt to identify the factors possibly responsible for deregulating proliferation of IEC-6 cells expressing activated MEK1, we have analyzed the expression of other cell cycle regulatory proteins and we found an up-regulation of cyclin D1, cdk4 and cdk2 expression and a strong reduction of p27 Kip1 levels in caMEK-expressing cells. Abnormalities in the expression of these cell cycle regulatory proteins have been previously reported in tumors of the small bowel (3) and colorectal carcinoma (38, 45, 54, 58, 59) . Regarding p27 Kip1 , the result is in agreement with our previous data showing that MEK/ERK cascade is required for p27 down-21 regulation and S phase entry in fibroblasts and IEC-6 cells (53). Moreover, it has been reported that reduced expression of p27 Kip1 is a predictive factor of a poor prognosis for patients with breast and colorectal cancers (38, 59) . Taken progression (55) . While some studies have reported that ERK1/2 activities are elevated in intestinal tumors (28, 35, 36) , others have shown no modulation or inhibition (21, 62) . In the present study, basal activity of ERK1/2 was slightly to moderately enhanced in both cell populations expressing the activated form of MEK1 (caMEK). However, stimulation of ERK activities in response to serum was not observed in either cell populations expressing caMEK.
One plausible explanation is that cells permanently stimulated by autoactive MEK1 are desensitized via multiple mechanisms including the previously reported ERK-mediated feedback inhibition of MEK (11) and possible increased basal levels of MAPK phosphatase (10, 25, 49 weeks, these cells had elevated ERK1/2 activities as well as a slightly more refractile and fibroblastic appearance (data not shown). These disparate observations suggest that selective pressures rather than direct signaling may determine the level of ERK activity in transformed cells and that these selective pressures may vary depending on cellular and genetic backgrounds.
In our view, the most interesting and novel finding of this study is the detection, Of particular note is that phosphorylation levels of ERK1b appeared to correlate very closely with IEC-6 cell proliferation. Indeed, in contrast to ERK1 and ERK2, ERK1b activity dramatically decreased as soon as pLXIN-and wtMEK-expressing cells reached confluence, to almost undetectable levels in post-confluent G1 arrested cells. In addition, ERK1b
was prominent in confluent caMEK-expressing cells which continued to proliferate well after confluence, indicating that ERK1b may contribute to the deregulation of contact inhibition cell growth and transformation of IEC-6 cells. Hence, it appears that in IEC-6 cells (Fig. 5D ) as well as in other transformed cells (25) , constitutive activation of the upstream components of the ERK cascade is not accompanied by a comparable activation of ERK1 and ERK2, at least initially.
This suggests that these two latter isoforms may be under tight down-regulation. However, ERK1b appears to escape this tight down-regulation in IEC-6 cells and appears to be the major responsive ERK isoform. Interestingly, in Ras-transformed Rat1 cells, there was higher expression of ERK1b, which was also more responsive than ERK1 and ERK2 to various extracellular treatments in transformed cells (68) . These observations are consistent with the fact that ERK1b is less sensitive to phosphatases (67 Images of colonies were also taken after staining with MTT (0.5mg/ml). 
